Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.35 |
| ▸ | PRKDC | P78527 | 3/20 | 0.33 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.32 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.32 |
| ▸ | TSPO | P30536 | 1/20 | 0.31 |
| ▸ | EDNRA | P25101 | 1/20 | 0.31 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.31 |
| ▸ | PPARG | P37231 | 3/20 | 0.31 |
| ▸ | PPARA | Q07869 | 2/20 | 0.31 |
| ▸ | CDC14B | O60729 | 2/20 | 0.30 |
| ▸ | CDC14A | Q9UNH5 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16596327 | 0.98 | ALOX5 (0.35) | ALOX5PRKDCPTGES2GGPS1TSPO | |
| SCHEMBL16596339 | 0.96 | ALOX5 (0.35) | ALOX5PRKDCPTGES2GGPS1HDAC8 | |
| SCHEMBL15926316 | 0.87 | ALOX5 (0.43) | ALOX5PRKDCPTGES2GGPS1TSPO | |
| SCHEMBL17122242 | 0.87 | ALOX5 (0.43) | ALOX5PRKDCPTGES2GGPS1TSPO | |
| SCHEMBL14902068 | 0.87 | ALOX5 (0.43) | ALOX5PRKDCPTGES2GGPS1TSPO | |
| SCHEMBL13969138 | 0.87 | ALOX5 (0.43) | ALOX5PRKDCPTGES2GGPS1TSPO | |
| SCHEMBL10306845 | 0.87 | ALOX5 (0.43) | ALOX5PRKDCPTGES2GGPS1TSPO | |
| SCHEMBL17122248 | 0.87 | ALOX5 (0.43) | ALOX5PRKDCPTGES2GGPS1TSPO | |
| SCHEMBL12136077 | 0.87 | ALOX5 (0.43) | ALOX5PRKDCPTGES2GGPS1TSPO | |
| SCHEMBL13969117 | 0.87 | ALOX5 (0.43) | ALOX5PRKDCPTGES2GGPS1TSPO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9425402-B2 | Polymerizable monomer, and material for organic device, hole injection/transport material, material for organic electroluminescence element and organic electroluminescent element each comprising polymer (polymeric compound) of the polymerizable monomer | IDEMITSU KOSAN CO., LTD. (JP) | 2016-08-23 | — | — | US | disclosed |
| US-9425402-B2 | Polymerizable monomer, and material for organic device, hole injection/transport material, material for organic electroluminescence element and organic electroluminescent element each comprising polymer (polymeric compound) of the polymerizable monomer | IDEMITSU KOSAN CO., LTD. (JP) | 2016-08-23 | — | — | US | disclosed |
| US-20150084031-A1 | NOVEL POLYMERIZABLE MONOMER, AND MATERIAL FOR ORGANIC DEVICE, HOLE INJECTION/TRANSPORT MATERIAL, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT AND ORGANIC ELECTROLUMINESCENT ELEMENT EACH COMPRISING POLYMER (POLYMERIC COMPOUND) OF THE POLYMERIZABLE MONOMER | IDEMITSU KOSAN CO (JP) | 2015-03-26 | — | — | US | disclosed |
| US-20150084031-A1 | NOVEL POLYMERIZABLE MONOMER, AND MATERIAL FOR ORGANIC DEVICE, HOLE INJECTION/TRANSPORT MATERIAL, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT AND ORGANIC ELECTROLUMINESCENT ELEMENT EACH COMPRISING POLYMER (POLYMERIC COMPOUND) OF THE POLYMERIZABLE MONOMER | IDEMITSU KOSAN CO (JP) | 2015-03-26 | — | — | US | disclosed |
| US-20110315964-A1 | NOVEL POLYMERIZABLE MONOMER, AND MATERIAL FOR ORGANIC DEVICE, HOLE INJECTION/TRANSPORT MATERIAL, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT AND ORGANIC ELECTROLUMINESCENT ELEMENT EACH COMPRISING POLYMER (POLYMERIC COMPOUND) OF THE POLYMERIZABLE MONOMER | IDEMITSU LOSAN CO., LTD. | 2011-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150084031-A1 | NOVEL POLYMERIZABLE MONOMER, AND MATERIAL FOR ORGANIC DEVICE, HOLE INJECTION/TRANSPORT MATERIAL, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT AND ORGANIC ELECTROLUMINESCENT ELEMENT EACH COMPRISING POLYMER (POLYMERIC COMPOUND) OF THE POLYMERIZABLE MONOMER | EPB41, USE1, EPB41L2 | ALOX5 919/4885PRKDC 4823/4885PTGES2 3167/4885 |
| US-20110315964-A1 | NOVEL POLYMERIZABLE MONOMER, AND MATERIAL FOR ORGANIC DEVICE, HOLE INJECTION/TRANSPORT MATERIAL, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT AND ORGANIC ELECTROLUMINESCENT ELEMENT EACH COMPRISING POLYMER (POLYMERIC COMPOUND) OF THE POLYMERIZABLE MONOMER | EPB41, USE1, EPB41L2 | ALOX5 869/4885PRKDC 4821/4885PTGES2 3160/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.